Insider · CIK 0001862734

KANTOFF AARON

Reports to the SEC for 3 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001862734

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.1K sh	—	—	20,100
2026-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,166 sh	—	—	6,333
2026-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,166 sh	—	—	3,167
2025-10-28	TRMLTourmaline Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−88.3K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2025-10-28	TRMLTourmaline Bio, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2025-10-24	TRMLTourmaline Bio, Inc.G Gift	Director	GGift	−5,000 sh	—	—	88,281
2025-09-05	TRMLTourmaline Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+37.9K sh	$0.13	+$4,925.7	83,281
2025-09-05	TRMLTourmaline Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$9.46	+$94.6K	93,281
2025-09-05	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−37.9K sh	—	—	0
2025-09-05	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-06-17	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.1K sh	—	—	20,100
2025-06-04	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2025-03-28	AVTXAvalo Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,167 sh	—	—	3,167
2025-03-28	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,167 sh	—	—	6,333
2024-08-13	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24.6K sh	—	—	24,600
2024-08-13	AVTXAvalo Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+9,500 sh	—	—	9,500
2024-06-05	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-10-24	TRMLTourmaline Bio, Inc.P Purchase	Director	PPurchase	+7,500 sh	$11.86	+$89K	45,391
2023-10-23	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-10-19	TRMLTourmaline Bio, Inc.A Award	Director	AAward	+37.9K sh	—	—	37,891
2023-10-19	TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.9K sh	—	—	37,890
2021-11-18	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+10K sh	$11.98	+$120K	60,000

Recent filings

Accepted (ET)
Jun 44
KANTOFF AARON0001862734-26-000004
SEC(opens sec.gov)
Mar 314
KANTOFF AARON0001862734-26-000002
SEC(opens sec.gov)
Oct 284
KANTOFF AARON0001862734-25-000006
SEC(opens sec.gov)
Oct 244
KANTOFF AARON0001862734-25-000004
SEC(opens sec.gov)
Sep 94
KANTOFF AARON0001415889-25-023997
SEC(opens sec.gov)
Jun 184
KANTOFF AARON0001578563-25-000321
SEC(opens sec.gov)
Jun 64
KANTOFF AARON0001827506-25-000084
SEC(opens sec.gov)
Apr 14
KANTOFF AARON0001578563-25-000201
SEC(opens sec.gov)
Aug 144
KANTOFF AARON0001578563-24-000367
SEC(opens sec.gov)
Jun 74
KANTOFF AARON0001827506-24-000054
SEC(opens sec.gov)
Oct 264
KANTOFF AARON0001209191-23-053674
SEC(opens sec.gov)
Oct 234
KANTOFF AARON0001209191-23-053397
SEC(opens sec.gov)

Companies

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087